nodes	percent_of_prediction	percent_of_DWPC	metapath
Lornoxicam—Piroxicam—Oxcarbazepine—epilepsy syndrome	0.451	1	CrCrCtD
Lornoxicam—PTGS2—epilepsy syndrome	0.196	1	CbGaD
Lornoxicam—PTGS1—Diazepam—epilepsy syndrome	0.0512	0.156	CbGbCtD
Lornoxicam—PTGS1—Valproic Acid—epilepsy syndrome	0.0404	0.123	CbGbCtD
Lornoxicam—CYP2C9—Trimethadione—epilepsy syndrome	0.0402	0.123	CbGbCtD
Lornoxicam—CYP2C9—Fosphenytoin—epilepsy syndrome	0.0378	0.115	CbGbCtD
Lornoxicam—CYP2C9—Carbamazepine—epilepsy syndrome	0.0272	0.0829	CbGbCtD
Lornoxicam—CYP2C9—Primidone—epilepsy syndrome	0.0254	0.0774	CbGbCtD
Lornoxicam—CYP2C9—Phenytoin—epilepsy syndrome	0.0244	0.0744	CbGbCtD
Lornoxicam—CYP2C9—Propofol—epilepsy syndrome	0.0227	0.0694	CbGbCtD
Lornoxicam—CYP2C9—Phenobarbital—epilepsy syndrome	0.0217	0.0663	CbGbCtD
Lornoxicam—CYP2C9—Diazepam—epilepsy syndrome	0.0206	0.0628	CbGbCtD
Lornoxicam—CYP2C9—Valproic Acid—epilepsy syndrome	0.0162	0.0495	CbGbCtD
Lornoxicam—Tenoxicam—PTGS2—epilepsy syndrome	0.000543	0.347	CrCbGaD
Lornoxicam—Meloxicam—PTGS2—epilepsy syndrome	0.000387	0.247	CrCbGaD
Lornoxicam—Piroxicam—PTGS2—epilepsy syndrome	0.000336	0.214	CrCbGaD
Lornoxicam—Piroxicam—ALB—epilepsy syndrome	0.000299	0.191	CrCbGaD
Lornoxicam—PTGS2—Spinal Cord Injury—FOS—epilepsy syndrome	3.37e-05	0.00144	CbGpPWpGaD
Lornoxicam—CYP2C9—Biological oxidations—CYP2D6—epilepsy syndrome	3.36e-05	0.00144	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—ABCB1—epilepsy syndrome	3.33e-05	0.00143	CbGpPWpGaD
Lornoxicam—CYP2C9—Metapathway biotransformation—CYP2D6—epilepsy syndrome	3.32e-05	0.00142	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—SLCO1A2—epilepsy syndrome	3.31e-05	0.00142	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—CCL2—epilepsy syndrome	3.29e-05	0.00141	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—EPM2A—epilepsy syndrome	3.21e-05	0.00137	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—NHLRC1—epilepsy syndrome	3.21e-05	0.00137	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—PNPO—epilepsy syndrome	3.21e-05	0.00137	CbGpPWpGaD
Lornoxicam—PTGS2—Selenium Micronutrient Network—IL1B—epilepsy syndrome	3.16e-05	0.00135	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—CA4—epilepsy syndrome	3.14e-05	0.00135	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—QDPR—epilepsy syndrome	3.14e-05	0.00135	CbGpPWpGaD
Lornoxicam—PTGS1—Biological oxidations—POMC—epilepsy syndrome	3.13e-05	0.00134	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	3.12e-05	0.00134	CbGpPWpGaD
Lornoxicam—CYP2C9—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	3.1e-05	0.00133	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—NEU1—epilepsy syndrome	3.02e-05	0.0013	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—SV2A—epilepsy syndrome	2.98e-05	0.00128	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—COX3—epilepsy syndrome	2.96e-05	0.00127	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—PDXK—epilepsy syndrome	2.93e-05	0.00126	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—GLUD1—epilepsy syndrome	2.93e-05	0.00126	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—FAR1—epilepsy syndrome	2.93e-05	0.00126	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—CERS1—epilepsy syndrome	2.93e-05	0.00126	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—L2HGDH—epilepsy syndrome	2.93e-05	0.00126	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—ADK—epilepsy syndrome	2.93e-05	0.00126	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—HSD17B4—epilepsy syndrome	2.91e-05	0.00125	CbGpPWpGaD
Lornoxicam—PTGS1—Selenium Micronutrient Network—TNF—epilepsy syndrome	2.88e-05	0.00124	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—KCNB1—epilepsy syndrome	2.8e-05	0.0012	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—SLC6A8—epilepsy syndrome	2.8e-05	0.0012	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—SLCO1A2—epilepsy syndrome	2.8e-05	0.0012	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—CACNA2D2—epilepsy syndrome	2.8e-05	0.0012	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—PFKL—epilepsy syndrome	2.8e-05	0.0012	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	2.74e-05	0.00117	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	2.72e-05	0.00117	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—PNPO—epilepsy syndrome	2.68e-05	0.00115	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—EPM2A—epilepsy syndrome	2.68e-05	0.00115	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—GAMT—epilepsy syndrome	2.68e-05	0.00115	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—NHLRC1—epilepsy syndrome	2.68e-05	0.00115	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—PFKL—epilepsy syndrome	2.66e-05	0.00114	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—ASAH1—epilepsy syndrome	2.64e-05	0.00113	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—CA13—epilepsy syndrome	2.56e-05	0.0011	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—ATM—epilepsy syndrome	2.56e-05	0.0011	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—NEU1—epilepsy syndrome	2.56e-05	0.0011	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—UPB1—epilepsy syndrome	2.56e-05	0.0011	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—ATIC—epilepsy syndrome	2.56e-05	0.0011	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—IL1B—epilepsy syndrome	2.5e-05	0.00107	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—QDPR—epilepsy syndrome	2.5e-05	0.00107	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—CA4—epilepsy syndrome	2.5e-05	0.00107	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—CASP3—epilepsy syndrome	2.49e-05	0.00107	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—HSD17B4—epilepsy syndrome	2.47e-05	0.00106	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—STX1B—epilepsy syndrome	2.43e-05	0.00104	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—GBE1—epilepsy syndrome	2.38e-05	0.00102	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—PPP1R3C—epilepsy syndrome	2.38e-05	0.00102	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—MMP9—epilepsy syndrome	2.35e-05	0.00101	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—COX3—epilepsy syndrome	2.35e-05	0.00101	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	2.33e-05	0.000999	CbGpPWpGaD
Lornoxicam—PTGS2—Selenium Micronutrient Network—TNF—epilepsy syndrome	2.29e-05	0.000982	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—CPSF4—epilepsy syndrome	2.26e-05	0.000969	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—PPP1R3C—epilepsy syndrome	2.26e-05	0.000969	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—GBE1—epilepsy syndrome	2.26e-05	0.000969	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—ASAH1—epilepsy syndrome	2.24e-05	0.000961	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—CASP8—epilepsy syndrome	2.24e-05	0.00096	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—KCNB1—epilepsy syndrome	2.22e-05	0.000954	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—CACNA2D2—epilepsy syndrome	2.22e-05	0.000954	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—SLCO1A2—epilepsy syndrome	2.22e-05	0.000954	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—PFKL—epilepsy syndrome	2.22e-05	0.000954	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—SLC6A8—epilepsy syndrome	2.22e-05	0.000954	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—STXBP1—epilepsy syndrome	2.18e-05	0.000935	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	2.17e-05	0.000932	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	2.16e-05	0.000927	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—ALAD—epilepsy syndrome	2.12e-05	0.000911	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—NT5E—epilepsy syndrome	2.12e-05	0.000911	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	2.06e-05	0.000885	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—UPB1—epilepsy syndrome	2.03e-05	0.000873	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—ATIC—epilepsy syndrome	2.03e-05	0.000873	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—NEU1—epilepsy syndrome	2.03e-05	0.000873	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—CACNA1A—epilepsy syndrome	2.03e-05	0.000869	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—ALDH7A1—epilepsy syndrome	2.03e-05	0.000869	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—FGF2—epilepsy syndrome	2.02e-05	0.000868	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—ST3GAL3—epilepsy syndrome	1.98e-05	0.00085	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—HSD17B4—epilepsy syndrome	1.96e-05	0.00084	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—ADK—epilepsy syndrome	1.94e-05	0.000834	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—PDXK—epilepsy syndrome	1.94e-05	0.000834	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—FAR1—epilepsy syndrome	1.94e-05	0.000834	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—L2HGDH—epilepsy syndrome	1.94e-05	0.000834	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—GLUD1—epilepsy syndrome	1.94e-05	0.000834	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—CERS1—epilepsy syndrome	1.94e-05	0.000834	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—ADSL—epilepsy syndrome	1.94e-05	0.000833	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—epilepsy syndrome	1.92e-05	0.000824	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—GLUL—epilepsy syndrome	1.9e-05	0.000817	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—GBE1—epilepsy syndrome	1.89e-05	0.000811	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—PPP1R3C—epilepsy syndrome	1.89e-05	0.000811	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—ST3GAL3—epilepsy syndrome	1.88e-05	0.000806	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—CACNA1D—epilepsy syndrome	1.87e-05	0.000802	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	1.85e-05	0.000793	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—TNF—epilepsy syndrome	1.81e-05	0.000777	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—ASAH1—epilepsy syndrome	1.78e-05	0.000763	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—EPM2A—epilepsy syndrome	1.78e-05	0.000762	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—PNPO—epilepsy syndrome	1.78e-05	0.000762	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—NHLRC1—epilepsy syndrome	1.78e-05	0.000762	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—GAMT—epilepsy syndrome	1.78e-05	0.000762	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—TXNRD1—epilepsy syndrome	1.75e-05	0.00075	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—STXBP1—epilepsy syndrome	1.73e-05	0.000742	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—AQP1—epilepsy syndrome	1.7e-05	0.000728	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—epilepsy syndrome	1.69e-05	0.000727	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—NT5E—epilepsy syndrome	1.69e-05	0.000723	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—ALAD—epilepsy syndrome	1.69e-05	0.000723	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—QDPR—epilepsy syndrome	1.65e-05	0.000709	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—CA4—epilepsy syndrome	1.65e-05	0.000709	CbGpPWpGaD
Lornoxicam—CYP2C9—Biological oxidations—POMC—epilepsy syndrome	1.65e-05	0.000707	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—epilepsy syndrome	1.65e-05	0.000706	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	1.63e-05	0.000699	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—CACNA1A—epilepsy syndrome	1.61e-05	0.00069	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—ALDH7A1—epilepsy syndrome	1.61e-05	0.00069	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—ST3GAL3—epilepsy syndrome	1.57e-05	0.000675	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—COX3—epilepsy syndrome	1.55e-05	0.000666	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—ADSL—epilepsy syndrome	1.54e-05	0.000661	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—CHRM3—epilepsy syndrome	1.54e-05	0.000658	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—KCNJ11—epilepsy syndrome	1.54e-05	0.000658	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—GLUL—epilepsy syndrome	1.51e-05	0.000649	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—CACNA1D—epilepsy syndrome	1.48e-05	0.000637	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	1.48e-05	0.000633	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—SLCO1A2—epilepsy syndrome	1.47e-05	0.000632	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—PFKL—epilepsy syndrome	1.47e-05	0.000632	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—KCNB1—epilepsy syndrome	1.47e-05	0.000632	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—CACNA2D2—epilepsy syndrome	1.47e-05	0.000632	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—SLC6A8—epilepsy syndrome	1.47e-05	0.000632	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	1.44e-05	0.000617	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	1.44e-05	0.000616	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	1.43e-05	0.000614	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.43e-05	0.000613	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.4e-05	0.000601	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—TXNRD1—epilepsy syndrome	1.39e-05	0.000595	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—EIF2AK2—epilepsy syndrome	1.37e-05	0.000587	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—AQP1—epilepsy syndrome	1.35e-05	0.000578	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—UPB1—epilepsy syndrome	1.35e-05	0.000578	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—NEU1—epilepsy syndrome	1.35e-05	0.000578	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—ATIC—epilepsy syndrome	1.35e-05	0.000578	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—HSD17B4—epilepsy syndrome	1.3e-05	0.000556	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	1.29e-05	0.000555	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—PPIA—epilepsy syndrome	1.27e-05	0.000543	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—GBE1—epilepsy syndrome	1.25e-05	0.000537	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—PPP1R3C—epilepsy syndrome	1.25e-05	0.000537	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—ABCG2—epilepsy syndrome	1.25e-05	0.000537	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	1.23e-05	0.000528	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	1.22e-05	0.000525	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—CYP2C19—epilepsy syndrome	1.22e-05	0.000523	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—CHRM3—epilepsy syndrome	1.22e-05	0.000523	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—KCNJ11—epilepsy syndrome	1.22e-05	0.000523	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—CYP11A1—epilepsy syndrome	1.21e-05	0.00052	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.2e-05	0.000516	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—ASAH1—epilepsy syndrome	1.18e-05	0.000505	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—STXBP1—epilepsy syndrome	1.15e-05	0.000491	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.13e-05	0.000487	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—NT5E—epilepsy syndrome	1.12e-05	0.000479	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—ALAD—epilepsy syndrome	1.12e-05	0.000479	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.11e-05	0.000477	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.1e-05	0.000471	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—CYP2D6—epilepsy syndrome	1.09e-05	0.000469	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—ALDH7A1—epilepsy syndrome	1.06e-05	0.000457	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—CACNA1A—epilepsy syndrome	1.06e-05	0.000457	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—ST3GAL3—epilepsy syndrome	1.04e-05	0.000447	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—ADRA2A—epilepsy syndrome	1.04e-05	0.000447	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—BCHE—epilepsy syndrome	1.04e-05	0.000445	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—ADSL—epilepsy syndrome	1.02e-05	0.000438	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—GLUL—epilepsy syndrome	1e-05	0.000429	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—ABCG2—epilepsy syndrome	9.93e-06	0.000426	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—SLC2A1—epilepsy syndrome	9.89e-06	0.000424	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—CACNA1D—epilepsy syndrome	9.83e-06	0.000422	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—PLCB1—epilepsy syndrome	9.78e-06	0.00042	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—TH—epilepsy syndrome	9.75e-06	0.000418	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—CYP2C19—epilepsy syndrome	9.68e-06	0.000415	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—CYP11A1—epilepsy syndrome	9.62e-06	0.000413	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	9.6e-06	0.000412	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	9.55e-06	0.00041	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—SLC2A1—epilepsy syndrome	9.38e-06	0.000402	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—JUNB—epilepsy syndrome	9.31e-06	0.000399	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—NOS1—epilepsy syndrome	9.24e-06	0.000396	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—TXNRD1—epilepsy syndrome	9.19e-06	0.000394	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	9.17e-06	0.000393	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—AQP1—epilepsy syndrome	8.92e-06	0.000383	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—HBEGF—epilepsy syndrome	8.82e-06	0.000378	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	8.71e-06	0.000374	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—CYP2D6—epilepsy syndrome	8.68e-06	0.000372	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—AKT3—epilepsy syndrome	8.65e-06	0.000371	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	8.57e-06	0.000368	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—ADAM10—epilepsy syndrome	8.45e-06	0.000363	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—ADRA2A—epilepsy syndrome	8.27e-06	0.000355	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—BCHE—epilepsy syndrome	8.23e-06	0.000353	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—HMOX1—epilepsy syndrome	8.14e-06	0.000349	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—CHRM3—epilepsy syndrome	8.07e-06	0.000346	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—KCNJ11—epilepsy syndrome	8.07e-06	0.000346	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—CAT—epilepsy syndrome	8.03e-06	0.000344	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—CDC42—epilepsy syndrome	7.9e-06	0.000339	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—SLC2A1—epilepsy syndrome	7.85e-06	0.000337	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—ABCB1—epilepsy syndrome	7.81e-06	0.000335	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—PLCB1—epilepsy syndrome	7.77e-06	0.000333	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—TH—epilepsy syndrome	7.74e-06	0.000332	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	7.52e-06	0.000322	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	7.36e-06	0.000316	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—GPX1—epilepsy syndrome	7.26e-06	0.000311	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—HES1—epilepsy syndrome	7.23e-06	0.00031	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—FYN—epilepsy syndrome	7.03e-06	0.000301	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—H2AFX—epilepsy syndrome	7e-06	0.0003	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—YWHAZ—epilepsy syndrome	6.76e-06	0.00029	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	6.58e-06	0.000282	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—CCR5—epilepsy syndrome	6.5e-06	0.000279	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—HMOX1—epilepsy syndrome	6.46e-06	0.000277	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	6.41e-06	0.000275	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—CAT—epilepsy syndrome	6.37e-06	0.000273	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	6.37e-06	0.000273	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—AGT—epilepsy syndrome	6.37e-06	0.000273	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	6.33e-06	0.000271	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—APOE—epilepsy syndrome	6.24e-06	0.000268	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—ABCB1—epilepsy syndrome	6.2e-06	0.000266	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—TSC2—epilepsy syndrome	6.04e-06	0.000259	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—APOE—epilepsy syndrome	5.91e-06	0.000254	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	5.77e-06	0.000247	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—GPX1—epilepsy syndrome	5.76e-06	0.000247	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	5.75e-06	0.000247	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—IL6ST—epilepsy syndrome	5.55e-06	0.000238	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—NOS2—epilepsy syndrome	5.51e-06	0.000236	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	5.47e-06	0.000235	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—BCHE—epilepsy syndrome	5.45e-06	0.000234	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—POMC—epilepsy syndrome	5.36e-06	0.00023	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	5.2e-06	0.000223	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	5.14e-06	0.000221	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—TH—epilepsy syndrome	5.13e-06	0.00022	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—AGT—epilepsy syndrome	5.05e-06	0.000217	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	5.05e-06	0.000216	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—APOE—epilepsy syndrome	4.95e-06	0.000212	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—ALB—epilepsy syndrome	4.89e-06	0.00021	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—FGF2—epilepsy syndrome	4.49e-06	0.000193	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	4.28e-06	0.000183	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—PTGS2—epilepsy syndrome	4.27e-06	0.000183	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—POMC—epilepsy syndrome	4.25e-06	0.000182	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—CAT—epilepsy syndrome	4.22e-06	0.000181	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	4.11e-06	0.000176	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—MTOR—epilepsy syndrome	4.09e-06	0.000175	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—ALB—epilepsy syndrome	3.88e-06	0.000166	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—GPX1—epilepsy syndrome	3.82e-06	0.000164	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—AGT—epilepsy syndrome	3.35e-06	0.000144	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—APOE—epilepsy syndrome	3.28e-06	0.000141	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—SRC—epilepsy syndrome	3.28e-06	0.000141	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—POMC—epilepsy syndrome	2.82e-06	0.000121	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—ALB—epilepsy syndrome	2.57e-06	0.00011	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	2.25e-06	9.64e-05	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—AKT1—epilepsy syndrome	2.15e-06	9.21e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—AKT1—epilepsy syndrome	2.04e-06	8.73e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—AKT1—epilepsy syndrome	1.71e-06	7.32e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—AKT1—epilepsy syndrome	1.13e-06	4.84e-05	CbGpPWpGaD
